Scientist holding various vials with 3d rendered molecules/cells inside

Mastering the Quantitative Bioanalysis of Large Peptides and Proteins:

A Case Study of GLP-1 Receptor Agonist Semaglutide in Plasma.

Episode 3
16:00 - 16:30 Greek time

As peptide drugs, such as GLP-1 receptor agonist Semaglutide become central in treatment of a range of therapeutic areas, reliable bioanalysis methods, supporting DMPK evaluations and onwards transition through clinical trials, are essential to their successful progression to market. Development of accurate and robust analytical quantitative methodologies for peptides brings inherent challenges in efficient mrm optimisation, non specific binding and assay sensitivity. This exclusive webinar will dive into the latest advancements in comprehensive LC‑MS/MS analytical workflows, resolving these challenges, and enabling efficient development of robust, sensitive large peptide LC‑MS/MS assays.

Join us as Samantha Ferries, Senior Applications Chemist at Waters Corporation, presents efficiency and performance benefit insights from her recent work in optimizing the LC-MS/MS quantification of Semaglutide in plasma.

Key Takeaways:

§  Learn step-by-step how to streamline bioanalysis workflows for large peptides such as Semaglutide.

§  Discover practical solutions to common obstacles like non-specific binding and efficient mrm optimisation.

§  Gain insights into boosting sensitivity without compromising the reliability of your bioanalytical methods.

Presented by:

Samantha Ferries
Senior Applications Chemist, UK Demo Lab
Waters Corporation

 

Samantha Ferries smiling at camera

Samantha Ferries received her PhD in proteomics from the University of Liverpool in 2018. Since joining Waters she has worked on a variety of application areas including Biomedical Research, Pharmaceuticals and Food & Environmental, with a focus on LCMS/MS method development. In 2021 Samantha was part of the team that worked to develop the SARS-CoV-2 LCMS Kit (RUO) to detect & quantify SARS-CoV-2 signature NCAP peptides.

As a recognized leader in your field, we’d like to offer you an exclusive opportunity to directly influence the future of LC-MS/MS software. We’re inviting a select group of experts like you to participate in a survey designed to create solutions that meet your lab's specific needs and enhance operational efficiency. Your insights will help us develop software that is not only powerful but tailored to streamline your workflow and boost productivity.

Take the Survey →

 

Newsletter

Sign up to Hellamco's Mailing List and check out our latest news.
HELLAMCO S.A. will process your personal data only for communication and updating purposes, will not distribute them on to third parties and will keep them in the database for 30 days. For more information regarding the processing of personal data and rights, please visit our relative privacy policy.